VALIANT LABORATORIES
Back to Income Statement
|
VALIANT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹-3.27 Cr | ₹-2.20 Cr | ₹0.32 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of VALIANT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-3.27 Cr |
| Mar2025 | ₹-2.20 Cr |
| Mar2024 | ₹0.32 Cr |
| Mar2023 | ₹29 Cr |
How is Consolidated Net Profit of VALIANT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.27 Cr | Negative | |
| Mar2025 | ₹-2.20 Cr | Negative | |
| Mar2024 | ₹0.32 Cr | -98.90 | |
| Mar2023 | ₹29 Cr | - | |
Compare Consolidated Net Profit of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹560.6 Cr | -7.7% | -19.5% | 26.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.7% |
-19.5% |
26.9% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses